a group of 193 patients with multiple myeloma ( mm ) consisting of cases treated only symptomatically or by nonsystematic therapy with cyclophosphamide or melphalan ( 1959-76 ) , and of patients given systematic polychemotherapy with intensive supportive treatment ( 1976-84 ) were subjected to prognostic analysis of the importance of mm stratification into two categories , poor and good risk .
C0010583
cyclophosphamide
C0026764
mm